Phase III clinical study of BAY 12-8039 (moxifloxacin) for respiratory tract infections

Hiroyuki Kobayashi, Nobuki Aoki, Yoshihito Niki, Akira Watanabe, Shin Kawai, Shigeki Odagiri, Shigeru Kohno, Keizo Yamaguchi, Atsushi Saito

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)

    Fingerprint Dive into the research topics of 'Phase III clinical study of BAY 12-8039 (moxifloxacin) for respiratory tract infections'. Together they form a unique fingerprint.

    Medicine & Life Sciences